Novartis Global Reorg: One Unit Won't Make the Cut, Says CEO

Mar 20, 2014


Novartis Chief Executive Joe Jimenez expects that at least one of the drugmaker's three sub-scale units - animal health, vaccines and over-the-counter medicines - won't make the cut as the CEO reshapes the company for what he expects to be a tough era in healthcare spending.

"I really wish we could make all three of those businesses global scale, but I think it's unlikely," Jimenez told Reuters.

Jimenez did not specify which of the three units was most likely to be sold, but mentioned OTC as a strong growth area. The review is due to be completed by the end of the summer.

Read the full Reuters press release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments